
|Videos|April 19, 2023
Determining Treatment Efficacy in the Treatment of Myasthenia Gravis
Author(s)A. Gordon Smith, MD, FAAN
A. Gordon Smith, MD, FAAN, discusses how to assess for treatment success and why the patient perspective is so important in deciding whether to change therapies.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
3
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
4
Building the Foundation for Earlier Alzheimer Disease Diagnosis
5

















